Literature DB >> 18329692

Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.

Takahiro Hasebe1, Shigeru Imoto, Tomoyuki Yokose, Gen-Ichiro Ishii, Motoki Iwasaki, Noriaki Wada.   

Abstract

The purpose of this study was to identify histologic factors significantly associated with initial organ-specific metastasis by 1044 invasive ductal carcinomas (IDCs) of the breast with and without adjuvant therapy, separately, according to nodal status and pathologic TNM stage status. The following histologic factors were prospectively analyzed by multivariate analyses for distant organ metastasis and bone metastasis in patients with IDC who did not receive adjuvant therapy, and for distant organ metastasis, bone metastasis, liver metastasis, and lung metastasis in patients with IDC who received adjuvant therapy: (1) invasive tumor size, (2) histologic grade, (3) tumor necrosis, (4) fibrotic focus (FF), (5) lymphatic invasion, (6) blood vessel invasion, (7) adipose tissue invasion, (8) skin invasion, (9) muscle invasion, (10) age, (11) estrogen (ER)/progesterone (PR) status, and (12) nodal status. The results showed that FF diameter greater than 8 mm and FF fibrosis grade 1 were the factors that most accurately predicted distant organ metastasis and bone metastasis in patients with IDC who did not receive adjuvant therapy. In patients with IDC who received adjuvant therapy, FF diameter greater than 8 mm was the factor that most accurately predicted bone metastasis, and the presence of tumor necrosis and ER-/PR- were very important predictive factors for metastasis to the lung. Ten or more nodal metastases (N3) were the factor that most accurately predicted liver metastasis. Based on these findings, FF characteristics can be concluded to be the most important histologic factors for predicting metastasis to the bone, the presence of tumor necrosis and ER-/PR- for predicting metastasis to the lung, and N3 for predicting metastasis to the liver.

Entities:  

Mesh:

Year:  2008        PMID: 18329692     DOI: 10.1016/j.humpath.2007.09.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.

Authors:  Min Shi; Dang-Hui Yu; Ying Chen; Chen-Yan Zhao; Jing Zhang; Qing-Hua Liu; Can-Rong Ni; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

2.  The expressions of autotaxin-lysophosphatidate signaling-related proteins in metastatic breast cancer.

Authors:  Su Jung Shim; Eunah Shin; Choong-Sik Lee; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.

Authors:  Yoon Jin Cha; Do Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Pathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study.

Authors:  Peter F Rambau; Philipo L Chalya; Mange M Manyama; Kahima J Jackson
Journal:  BMC Res Notes       Date:  2011-06-22

5.  Expression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site.

Authors:  Hye Min Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

6.  Expression of Yes-associated protein (YAP) in metastatic breast cancer.

Authors:  Hye Min Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  c-erbB-2 and the "triple-state" in early breast carcinomas.

Authors:  Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I Koukourakis; Alexandra Giatromanolaki
Journal:  Med Oncol       Date:  2009-06-23       Impact factor: 3.064

8.  Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer.

Authors:  Diana Donovan; Laura Urquhart; Una Hopkins; Sandra Knight; Laura Moore
Journal:  Clin Med Insights Oncol       Date:  2014-05-07

9.  Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.

Authors:  Yoon Yang Jung; Hye Min Kim; Ja Seung Koo
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Site-specific metabolic phenotypes in metastatic breast cancer.

Authors:  Hye Min Kim; Woo Hee Jung; Ja Seung Koo
Journal:  J Transl Med       Date:  2014-12-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.